Skip to main content
. 2011 Aug 22;2(6):1097–1103. doi: 10.3892/etm.2011.340

Table II.

Patient characteristics.

Characteristic n (%)
mRNA analysis population 57 (100)
Gender
  Male 39 (68)
  Female 18 (32)
Age (years)
  Median 65
  Range 39–80
  <65 25 (44)
  ≥65 32 (56)
UICC T
  T1/2 2 (4)
  T3/4 55 (96)
UICC N
  N(−) 15 (26)
  N(+) 42 (74)
UICC M
  M(−) 55 (96)
  M(+) 2 (4)
UICC stage
  I–II 55 (96)
  III–IV 2 (4)
Histology
  Poor 4 (7)
  Moderate 44 (77)
  Well 3 (5)
  Other 6 (11)
Adjuvant chemotherapy regimen
  Gemcitabine 42 (74)
  S-1 15 (26)